Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sensei Biotherapeutics
Biotech
Sensei lays off 46% of staff, closes site to fund cancer trial
Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to take its immune checkpoint inhibitor though phase 2.
James Waldron
Nov 14, 2024 9:38am
Former AbbVie R&D chief tapped to run Tessera—Chutes & Ladders
Jun 3, 2022 9:30am
Sensei clinches $133M IPO to advance personalized cancer meds
Feb 4, 2021 8:10am
Sensei raises $29M to advance anti-cancer bacteriophage pipeline
Oct 9, 2020 9:35am
Novavax appoints AZ vet Dubovsky to CMO post—Chutes & Ladders
Jun 19, 2020 9:30am
Sensei Biotherapeutics nabs new CMO from Merus
Jun 15, 2020 9:40am
